Institute for the Study of Aging (ISOA) Report issue

Academic/Hospital Phase 1 Phase 2
Founded: New York NY United States (1998)

Organization Overview

First Clinical Trial
2000
NCT00024531
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (4)

atorvastatin (lipitor) (1 trial)

curcumin (1 trial)

mifepristone (mifeprex) (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Phase 1 Trials (1)

cenegermin-bkbj (oxervate) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 2)

Cognitive Dysfunction (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 5